BiotechTube
GenomOncology

GenomOncology

Cleveland, United States· Est.
genomoncology.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5M

Overview

GenomOncology is a private, revenue-generating company offering a specialized software platform that transforms fragmented genomic and clinical data into unified, actionable intelligence for cancer care teams. Founded in 2012 and headquartered in Cleveland, Ohio, the company serves over 50 leading healthcare institutions, including NCI/NCCN-designated providers and major molecular labs. Its core value proposition lies in automating and embedding clinical decision support and trial matching directly into existing clinical workflows, aiming to reduce operational bottlenecks and improve patient outcomes in precision oncology.

Oncology

Technology Platform

A unified, configurable software platform for genomic data integration, analysis, and clinical decision support in precision oncology. It features a Molecular Pathology Workbench for report generation, a real-time Clinical Trial Optimization engine with transparent AI matching, and embedded decision support tools, all designed to integrate into existing clinical workflows.

Funding History

2
Total raised:$5M
Series A$3.5M
Seed$1.5M

Opportunities

The rapid growth of precision oncology and complex genomic data creates a large market for integrated software platforms.
There is significant opportunity to expand within existing healthcare systems and to form new partnerships with diagnostic labs, pharmaceutical companies (for trial enrollment), and research networks.
The shift towards value-based care incentivizes tools that improve treatment efficiency and outcomes.

Risk Factors

Faces competition from large EHR vendors, specialized oncology software companies, and diagnostic labs with their own informatics.
Long sales cycles and the need to demonstrate clear ROI to healthcare institutions can hinder growth.
The evolving regulatory landscape for AI/ML in clinical software and changes in genomic testing reimbursement pose indirect risks.

Competitive Landscape

GenomOncology competes in the clinical decision support and genomic data interpretation market. Key competitors include large EHR providers (Epic, Cerner), oncology-specific EHRs, informatics suites from large diagnostic labs (e.g., Foundation Medicine), and other independent software vendors. Differentiation is based on deep oncology-specific workflow integration, configurable and transparent AI for trial matching, and a focus on unifying fragmented data sources.

More companies in Diagnostics & Precision Medicine →More companies in United States →